A Phase III, Multicenter, Randomized, Open-Label Study Comparing Atezolizumab (Anti Pd-L1 Antibody) In Combination with Adjuvant Anthracycline/Taxane-Based Chemotherapy versus Chemotherapy Alone In Patients with Operable Triple-Negative Breast Cancer
- Harris, Marion (Primary Chief Investigator (PCI))
Project: Research